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Background. Local adipose tissue (AT) cooling is used to manage obesity and overweight, but the mechanism is unclear. *e
current view is that acute local cooling of AT induces adipocyte cell disruption and inﬂammation (“cryolipolysis”) that lead to
adipocyte cell death, with loss of subcutaneous fat being recorded over a prolonged period of weeks/months. A contrasting view is
that AT loss via targeted cryotherapy might be mediated by thermogenic fat metabolism without cell disruption.Methods. In this
retrospective study of individuals presenting for cryotherapy to the Clinic BioEsthetic, Paris, France, we recorded waist cir-
cumference, body weight, and body mass index (BMI) by direct measurement and by whole-body dual-energy X-ray
absorptiometric scanning. In select individuals, blood analysis of markers of inﬂammation and fat mobilization was performed
before and after the procedure. Results. We report that (i) single sessions of tissue cryotherapy lead to signiﬁcant loss of tissue
volume in the time frame of hours and (ii) multiple daily procedures lead to a cumulative decline in AT, as assessed by waist
circumference, body weight, and BMI, conﬁrmed by whole-body dual-energy X-ray absorptiometric scanning. In addition, (iii)
blood analysis following tissue cryotherapy found no signiﬁcant changes in biochemical parameters including markers of in-
ﬂammation. Moreover, (iv) calculations of heat extracted and of compensatory weight loss taking place through thermogenesis are
substantially consistent with the observed loss of AT. Conclusions. *ese ﬁndings argue that cold-induced thermogenesis
(“cryothermogenesis”) rather than adipocyte disruption underlies the reduction in AT volume, raising the prospect that more
intensive cryotherapy may be a viable option for combating obesity and overweight.
1. Introduction
*e growing prevalence of obesity and overweight is of
increasing concern because deposition of subvisceral fat in
obesity is associated with increased risk of life-threatening
conditions including cardiovascular disease, diabetes, met-
abolic syndrome, and some forms of cancer [1–3].
Dietary interventions in obesity generally bring only
short-term beneﬁts, and attention has focused on alternative
strategies for adipose tissue (AT) ablation including surgical
removal and radiofrequency, ultrasound, and laser treat-
ment [4, 5]. An alternative approach, body cooling, involves
either environmental cold exposure (e.g., [6–9]) or devices to
reduce the skin temperature (e.g., [10, 11]), leading to
systemic or local exposure of fatty tissues to active cooling
[12–15]. With respect to tissue cooling, it has been hy-
pothesized that adipocytes are more sensitive to cooling than
other tissue types and that cooling leads to crystallization of
cytoplasmic lipids, disruption of cellular integrity, cell death
via apoptosis/necrosis, and inﬂammation, leading to selec-
tive loss of ATover a period of weeks to months by a process
dubbed “selective cryolysis” or “cryolipolysis” ([12, 16],
reviewed in [14, 17]). Selective sensitivity of fatty tissue to
cold has a long history, and for over a century there have
been observations of local adipose tissue lesions in regions
exposed to local cooling [15]. However, a competing hy-
pothesis is that cold exposure might act by boosting energy
expenditure via fat metabolism and thermogenesis
(e.g., [18–20]), leading to reduction of fat mass without cell
disruption. *is possibility was long overlooked because it
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was thought that thermogenic adipose tissue, widely de-
scribed in rodents, was not present in humans (see below).
Two principal types of AT have been described in
mammals: white adipose tissue (WAT) and brown adipose
tissue (BAT). *e most abundant adipose cell types are the
white adipocytes that contain a single intracellular lipid
droplet and localize to speciﬁc depots within the body.
White adipocytes store excess energy as lipid and function to
regulate systemic energy balance through the release of
adipokines that target peripheral tissues [21] and also target
the brain to modulate appetite in response to excess energy
supply [22, 23]. WAT expands by increasing the adipocyte
size and/or number, and WAT expansion serves to protect
tissues including the muscle and liver from lipotoxicity [24].
Depots of WAT are generally classiﬁed as visceral or sub-
cutaneous, with the latter being considered to be protective,
whereas the former are linked to metabolic disease [24–26].
*e second major type of the adipose cell, the brown
adipocyte, was overlooked in humans for many years until
imaging with [18F]-ﬂuorodeoxyglucose revealed that, like
mice, humans also have extensive depots of BAT ([27],
reviewed in [28, 29]). In contrast to WAT, BAT adipocytes
express uncoupling protein (UCP1) that permits mito-
chondria to metabolize fat via β-oxidation to generate heat
[29, 30]. Brown adipocytes are widely distributed in the
supraclavicular and neck regions, with additional para-
vertebral, mediastinal, para-aortic, and suprarenal locali-
zations [27, 29, 31], and oxidative metabolism in BAT has
been demonstrated to contribute directly to increased en-
ergy expenditure in response to acute cold exposure in
humans [32]. Importantly, numbers of brown adipocytes are
thought to decline with age [8, 33], and this may contribute
to increasing incidence of overweight with age.
BAT depots can expand in both metabolic rate and cell
number to maintain the body temperature in response to
cooling. By triggering BAT lipolysis and thermogenesis, cold
exposure can reduce the body pool of fatty acids [19, 32], and
prolonged cold exposure can induce the proliferation and
diﬀerentiation of precursors, leading to an increase in brown
adipocyte numbers [34–36]. *ere is also evidence that
WATcan partly convert to BAT-like adipocytes in response
to diﬀerent stimuli [37, 38], suggesting that redirection of
WAT precursors towards BAT (“browning”) in response to
cold exposure could contribute to obesity control.
Systemic/environmental cold exposure has inconveniences
as a modality for managing obesity/overweight, and attention
has focused on the application of cold temperatures directly to
fat deposits with a view to stimulating dissipation of lipid
depots. FDA approval was given in 2010 for the use of a tissue
cryotherapy device aimed at reducing abdominal fat; the safety
and eﬃcacy of the procedure have now been widely demon-
strated (reviewed in [39, 40]).
Cooling of fatty tissue has been suggested to lead to
adipocyte disruption/cell death and local inﬂammation
(“selective cryolysis” or “cryolipolysis”) that precede AT loss
[12, 16]. *e mechanistic basis is of direct clinical relevance
because if tissue cryotherapy operates by inducing adipocyte
cell death, then repeat procedures must be widely spaced
(e.g., 8 weeks apart) to allow removal of cell debris and
resolution of inﬂammation [12, 39]. Indeed, it has been reported
that beneﬁcial results are only observed after weeks or months,
the recommended area for application is limited to local
prominences of fatty tissue (“saddlebags”), and it is necessary to
wait for a long period (1–3 months) before proceeding to a new
zone [12, 14, 16, 17]. By contrast, others have suggested the
possibility that the beneﬁcial eﬀects of body cooling might take
place by increasing nonshivering thermogenesis (e.g., [18, 19]);
if conﬁrmed, this would allow simultaneous application to
diﬀerent body regions, and moreover, repeated cryoexposure
might be eﬀective in driving the loss of adipose tissue [18].
In this retrospective study, we have addressed this issue
(i) by studying changes in obesity-related parameters in
response to single versus multiple/serial applications of
tissue cryotherapy, (ii) by blood analysis for markers of
inﬂammation and lipid mobilization, and (iii) by compar-
isons of proﬁles of weight loss against calculations of energy
expenditure. We report that cryoexposure is not associated
with biomarkers of inﬂammation and that serial daily ap-
plications lead to a cumulative reduction of waist circum-
ference and BMI accompanied by AT reductions, conﬁrmed
by absorptiometric whole-body scanning. We also report
that the extent of AT loss is consistent with the extent of loss
predicted from calculated energy expenditure through com-
pensatory fat metabolism and thermogenesis.
2. Methods
2.1. Subjects and Ethical Permissions. In this retrospective
study, two groups of participants attending a medical clinic
(SAS Clinic BioEsthetic) in Paris, France, in the period
January 2016 to September 2016 were investigated: group 1,
n � 18 (three treatments), and group 2, n � 7 (six treatments
monitored by whole-body scanning) (summarized in Table 1).
All had a BMI in either the normal range (67–71%) or
overweight/obese (29–33%), and no subject undertaking the
Table 1: Subject group parameters.
Minimum Maximum Mean
Group 1 (n � 18)
M/F M� 22%
Age (years) 19 82 54.3
Waist (cm) 70.1 112.5 85
Weight (kg) 55.8 96.4 71.7
BMI 18.9 32.7 24.8
Underweight BMI, <18.5 0%
Normal range BMI, <25 67%
Overweight BMI, 25–30 22%
Obese BMI, >30 11%
Group 2 (n � 7)
M/F M� 14%
Age (years) 19 70 53.6
Waist (cm) 75.5 90 82.9
Weight (kg) 50.3 72.5 67.5
BMI 19.2 29.9 24.2
Underweight BMI, <18.5 0%
Normal range BMI, <25 71%
Overweight BMI, 25–30 29%
Obese BMI, >30 0%
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procedure was classiﬁed as underweight. Tissue cryotherapy,
a noninvasive procedure [14, 17, 40, 41], does not require
formal institutional ethical approval. All participants gave
written informed consent for their involvement in the study,
data analysis, and preparation for publication. Exclusion cri-
teria were (i) allergic/inﬂammatory reaction to cold: a positive
reaction (redness/inﬂammation, rash, itchiness, blistering, and
any other adverse eﬀects) on application of an ice cube for 2
minutes to the skin of the inner arm, or (ii) evidence/history of
cryoglobulinemia and Hodgkin’s or non-Hodgkin’s lym-
phoma, including Waldenstrom macroglobulinemia.
2.2. Tissue Cryotherapy Procedure. *e procedure employed
a commercial tissue cryotherapy device (FG6601-006, ADSS,
Republic of China) equipped with multiple cooling probes
(cooling area per probe 20× 8 cm).Weight, height, and waist
and thigh (left) circumferences were recorded; BMI was
calculated automatically using a commercial apparatus
(model SC240MA, Tanita, Japan). A layer of wetted paper
(glycerol-based wetting membrane, ETG-111-200, Freeze-
fats, Republic of China) was applied to the lower back and
hips of the reclining subject, followed by symmetrical ap-
plication of six probes placed pairwise accompanied by
gentle suction to improve contact. *e cooling temperature
was set to −10°C, declining to −5°C over 30 minutes; the
application duration was 40 minutes. Subjects then lay
supine, and the procedure was repeated on fatty deposits on
the lower abdomen and hips, again for 40 minutes (total
duration 1.33 h). Oral (sublingual) temperature, a proxy for
core temperature, was recorded before and at 1, 5, 10, and 30
minutes after the procedure. Local skin surface temperature
at the site of treatment was recorded using a laser ther-
mometer 1, 5, 10, 30, and 60 minutes after removal of the
cooling probe. Body weight, waist and thigh circumferences,
and BMI were recorded again within 1 h after the procedure.
Group 1 participants underwent three procedures; group 2
participants volunteered for multiple procedures and agreed
to undergo whole-body scanning before and after three and
six sequential procedures.
2.3. Whole-Body Scanning. Whole-body assessment of fat
content employed a Lunar iDXA dual-energy X-ray absorp-
tiometry scanner (GE Healthcare Lunar, Madison, WI, USA)
in which the subjects lay supine; the maximum scan time was
7.2 minutes. Scanning and recording of results were according
to the manufacturer’s instructions.
2.4. Analysis of Blood Proﬁles. Seven subjects provided
a comprehensive test battery of blood analyses before and 3
days after receiving tissue cryotherapy. Blood analyses were
performed by a certiﬁed bioanalytical laboratory (Labo-
ratoire Philippe Auguste, Paris, France) and included
markers of (i) inﬂammation (monocyte counts, C-reactive
protein, and neopterin, a marker of macrophage/dendritic
cell activation); (ii) insulin resistance (IR) and homeostasis
model assessment (HOMA) test (insulin-glucose balance);
(iii) lipid proﬁle (total cholesterol (TC) and high-density
lipoprotein (HDL)) including markers of hepatic steatosis
and fat metabolism (alanine aminotransferase (ALAT), alkaline
phosphatase (ALP), aspartate aminotransferase (AST), gamma-
glutamyl transferase (GGT), triglyceride, (TG), and their
relevant ratios); and (iv) thyroid hormone (TSH, total T4,
and free T4).
2.5. Precision/Variability. To assess the precision/variability
of individual measures of weight, BMI, fat mass, and waist and
thigh circumferences and to exclude this as a signiﬁcant
complicating factor, a random sample of individuals (n � 12)
from group 1 were subjected to three to ﬁve repeat measures of
these parameters at the same time by diﬀerent operators, and
the standard deviations were calculated: repeat measure SDs
were weight 0.032 kg (0.046%), BMI 0.002 units (0.111%),
waist circumference 0.76 cm (0.9%), and thigh circumference
0.79 cm (1.470%); all with the exception of thigh circumference
were smaller than the changes observed following the pro-
cedure, validating statistical analysis.
2.6. StatisticalAnalysis. In this retrospective study, there was
a tendency for subjects with lower indices of obesity to opt
for more frequent applications of the procedure (not pre-
sented), and to avoid bias in statistical comparisons, all
values were expressed as percentages of the baseline. As-
sessment of statistical signiﬁcance employed normalized
means and SDs; results were evaluated using unpaired
Student’s t-tests, and the statistical signiﬁcance was set at
p≤ 0.05.
3. Results
3.1. Local Cooling Produces Decrements in Waist Circum-
ference. *e cryotherapy procedure (summary timelines are
given in Figure 1) was applied to a ﬁrst series of 18 subjects
(group 1), and waist circumference, body weight, BMI, and
local and oral (sublingual) temperatures were recorded
before and after a single application of local abdominal tissue
cooling. Local skin surface temperature immediately be-
neath the cooling probe was variable within the region but
did not fall below +6°C. *ere was typically local reddening
of the skin consistent with increased local blood circulation.
No superﬁcial skin damage of any type was observed, there
was no evidence of tissue “solidiﬁcation,” no shivering
thermogenesis was observed, and no participant reported
any adverse events.
Because indices such as waist and limb circumferences
are to some extent subjective measures, we carefully ex-
amined the variability/precision of the values. *ere was
some repeat measure variability, but the extent of inter-
measure variability was generally less than the documented
changes (for details, see Methods), permitting statistical
analysis. In addition, there were no statistically signiﬁcant
diﬀerences in the responses of male and female subjects (not
presented), and all analyses addressed the means and SDs
across the entire group.
As shown in Figure 2(a), there was a mean reduction of
3.0% of the waist circumference (mean 2.55 cm; p< 0.0001)
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Figure 1: Timeline of the cryotherapy procedure. (a) Standard procedure in which physiological parameters (weight, BMI, fat mass, and
waist and thigh circumferences) are measured (MP) before and after cryotherapy (CRYO, duration 1.33 h) in all procedures (not to scale in
(b) and (c)). (b) Group 1 (n  18) underwent the procedure on 3 serial days. (c) Group 2 (n  7) underwent the procedure on 6 serial days;
dual-energy X-ray absorptiometry (DXA) scanning was performed as indicated before the procedure and following three and six
procedures.
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Figure 2: Percentage change in (a) waist circumference and (b) thigh circumference, following single abdominal applications of tissue
cryotherapy (group 1; duration of the procedure, ca. 1.33 h; time following the procedure, ca. 1 h). Error bars indicate SD; error bars are not
shown for the left-hand plots in each panel because these were normalized to 100%.
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within 3 h following the procedure, but there was no sig-
nicant change in thigh circumference (Figure 2(b)). e
body temperature (oral) rose from mean 35.8 to mean 36.1
(+0.3°C), but the change was not signicant; changes in
weight and BMI on single applications also fell short of
statistical signicance (not presented; see below). ere was
a small trend towards a reduction in cryotreatment-induced
weight and BMI changes as a function of age, although the
trend was not statistically signicant (p  0.2): some older
individuals displayed substantial reductions in waist cir-
cumference and some young subjects displayed low re-
sponses (not presented).
To address a possible delay/time-dependent eect,
measurements were performed 5–10 days after the pro-
cedure but without further tissue cryotherapy. e extent of
the reduction in waist circumference (∼1 week after cryo-
therapy; mean 3.3 cm; 3.9%; SD 3.09 as percent) did not
achieve statistical signicance versus the reduction observed
immediately following a single procedure (mean 2.55 cm;
3.0%; SD 2.71 as percent; not presented), although there
was a trend towards further reduction.
3.2.Multiple Applications Produce Incremental Loss ofWeight
and BMI. We then investigated whether serial daily applica-
tions of tissue cryotherapy might produce greater losses of AT.
Group 1 subjects undertook subsequent procedures on days 2
and 3 under the same conditions and for the same duration as
on day 1. As shown in Figure 3, in addition to a signicant
(p  0.003) decline in waist circumference (mean 2.8 cm;
3.3%), signicant reductions in both body weight (mean
0.53 kg; 0.73%;p  0.005) and BMI (0.2 units; 1.1%;p  0.012)
were recorded following three procedures (Figure 3).
3.3. Whole-Body Scanning Conrms AT Loss. To rigorously
conrm changes in body mass composition, individuals in
group 2 volunteered for independent evaluation via whole-
body dual-energy X-ray absorptiometry and computerized
calculation of body fat mass content (%) before and after
three procedures and again following six procedures; BMI in
these subjects was measured as before. Signicant declines in
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Figure 3: Decrement in (a) waist circumference, (b) weight, and (c) BMI following three sequential daily applications of tissue cryotherapy.
Error bars indicate SD; error bars are not shown for the left-hand plots in each panel because these were normalized to 100%.
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Figure 4: Progressive decline in BMI (expressed as %) in group 2
undergoing six rounds of tissue cryotherapy. Although all in-
dividuals responded, the gure illustrates the interindividual
variability, in accord with other studies (e.g., [18, 32]).
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both parameters were seen following three applications (not
presented), and, following six applications, mean scanning-
based fat mass was reduced by ∼3.8% (p  0.02 versus
baseline, paralleling the reduction in independently assessed
BMI (∼2.1%; 0.42 units; p  0.007 versus baseline; Figure 4
and 5). Dual-energy X-ray absorptiometry thus accords with
other independent measures of adipose content (waist cir-
cumference, body weight, and BMI) and conrms that serial
tissue cooling procedures lead to a progressive reduction of
body fat content.
3.4. Biomedical Parameters. To assess whether local tissue
cooling is associated with adipocyte disruption, blood
analysis of markers of in¦ammation and lipid mobilization
(as given in Methods) was carried out on seven randomly
selected subjects before and 3 days after six serial daily
procedures (Supplementary Materials S1). is timepoint
was chosen tomaximize the likelihood of detectable systemic
changes because fat “freezing” and resolution, implied to
underlie cryolipolysis, are likely to take days or more to
resolve. One subject displayed an elevated HOMA-IR value
(5.16) before the procedure, but this normalized at follow-up
after treatment (1.19; Supplementary Materials S1), and in
one subject there was an elevation of neopterin for reasons
unknown. As expected, there was a nonsignicant trend for
all treated subjects who are overweight/obese to have an
elevated HOMA-IR score (Supplementary Materials S1). All
other proles before and after the procedure were un-
remarkable. Importantly (except as noted above), there was
no indication of in¦ammation or abnormal lipid proles.
Tissue cryotherapy in these subjects was thus not associated
with systemic in¦ammation or changes in blood lipid
proles that would be consistent with ongoing cell lysis/
adipocyte disruption.
4. Discussion
We report that serial daily abdominal tissue cooling (tissue
cryotherapy) produces progressive loss of AT, conrmed by
dual-energy X-ray absorptiometry. No adverse events were
reported for the participants in this study, in accordance
with previous studies and meta-analysis that the tissue
cryotherapy procedure is safe and well tolerated
[14, 17, 40, 41]. Following six procedures, there was
a parallel decline in BMI (∼2%; 0.5 units) and fat mass
content determined by whole-body scanning (∼3.8%).
Under carefully controlled conditions, no consistent changes
in biochemical parameters or adverse events were reported
following six procedures, and there was no evidence of sys-
temic in¦ammation or abnormal fat mobilization indicative of
disruption of cellular integrity and cell death via apoptosis/necrosis
(“cryolipolysis”).
Our ndings cast light on the mechanism of AT loss. It
has been suggested that the presence of fatty deposits renders
adipose cells highly susceptible to cell killing produced by
cooling, mediated by aggregation/crystallization mecha-
nisms leading to cell disruption and/or apoptotic/necrotic
cell death, followed by local in¦ammation and a protracted
period (weeks) of immune cell inltration and clearance of
cell debris [12, 14, 16, 17, 39]. However, in contrast to earlier
reports that there is no evident change in body fat shortly
after the procedure [14, 16, 17, 39], we report signicant
benecial eects within a short time frame after the
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Figure 5: Decline in BMI and fat mass (FM) with six treatments. (a) e box-and-whisker plot (median, quartiles, range) of BMI and
computer-generated FM% values by whole-body dual-energy X-ray absorptiometry scanning in group 2 before (baseline) and after six
rounds of the tissue cooling procedure. (b) A representative example of the output of the dual-energy X-ray absorptiometry body scanner in
one subject before the procedure (1), after three procedures (2), and after six procedures (3).
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procedure, an eﬀect too rapid to be explained by cell death
and clearance. In addition, serial daily applications of tissue
cooling produced further progressive losses of waist cir-
cumference, body weight, BMI, and body fat mass that could
be incompatible with the cell disruption hypothesis. Fur-
thermore, biochemical analysis revealed no adverse changes,
in accordance with a previous report that also found no
signiﬁcant changes in blood parameters following cooling
applied using a liquid-conditioned tube suit at 18°C [32].*e
lack of markers of inﬂammation or lipid mobilization in
subjects undertaking the procedure argues against the ad-
ipocyte disruption hypothesis and instead points to adi-
pocyte cell volume reduction via thermogenesis, with
conservation of cellular integrity. In support, the body
temperature (oral) was maintained (+0.3°C) despite intense
local cooling, suggesting that thermogenesis is taking place.
Rigorous demonstration that thermogenesis is taking place
will require invasive histological analysis of markers of ther-
mogenesis (e.g., UCP1 mRNA) and/or radiotracing of lipid
mobilization and oxidation, which was not possible in this
retrospective analysis. We therefore used a diﬀerent approach
to address whether thermogenesis in response to heat loss
could underlie the observed decline in fatty tissue. We studied
the relationship between measured physiological parameters
and calculated measures of heat extraction and compensatory
thermogenesis. First, using a simpliﬁed model of abdominal
obesity (Supplementary Materials S2), the mean decline of
circumference following three procedures (3.3%) was esti-
mated to equate to a tissue loss of 0.50 kg, close to the observed
mean decline of 0.53 kg, pointing to internal consistency of
these independently measured values.
Second, data supplied by the manufacturer of the cryo-
therapy machine, revised according to direct measurements in
a model system (Supplementary Materials S3), allowed us to
calculate that, over a single session, the total heat extracted is in
the vicinity of 1330 kcal. In the absence of compensatory
thermogenesis, this would lead to a calculated mean fall in
a body temperature of 18°C (Supplementary Materials S3),
whereas no decline was observed (instead there was a small
increase, +0.3°C; see earlier), indicating that thermogenesis is
taking place.
*ird, we compared the calculated quantity of heat
extracted against the extent of tissue loss expected via com-
pensatory thermogenesis. After three sessions (ca. 3990 kcal
extracted), at a consensus value of 7710 kcal per kg fatty tissue
metabolized (SupplementaryMaterials S3), the expectedmean
weight loss is 0.52 kg, compared with the observed weight loss
of 0.54 kg. *e mean estimated weight loss taking place via
thermogenesis alone (calculated from heat extracted; no
change in the body temperature) is therefore close to the actual
weight loss. *is broad equivalence between fat mass loss and
energy expenditure substantiates, in accordance with previous
reports [18, 19, 32], that energy expenditure taking place via
cold-induced fat metabolism and thermogenesis may alone
explain the beneﬁcial eﬀects of cold treatment.
Heat generation in response to cooling has generally been
attributed to fatty acid β-oxidation. Exposure of mammalian
cells to low temperatures (“cold shock”) causes widespread
changes in gene expression (reviewed in [42, 43]). *ere is
strong evidence that fat cells can directly sense low temper-
ature and activate thermogenesis [20]; cold-induced upregu-
lation of the transcription factor Zfp516 induces the expression
of UCP1 [44], and BAT metabolic activity increases very
rapidly following cold exposure [45]. Indeed, cold exposure
induces rapid triglyceride uptake from the blood [30], and
adipose triglyceride lipase activity is instrumental in BAT fat
mobilization [46, 47]. Nevertheless, the exclusive emphasis on
fatty acid oxidation by BAT may not be correct. It has been
reported that, in human cold exposure, lipid oxidation only
increased by 63%, whereas carbohydrate oxidation increased
by 588% [48]. BAT contains signiﬁcant endogenous glycogen
stores, and cold exposure in rats and mice increases BAT
glucose uptake by an order of magnitude [49, 50]. Glycolysis
could thereforemake amajor contribution to increased energy
expenditure during cold exposure, although short-term energy
expenditure via glycolysis may well subsequently equilibrate
via longer-term cellular fat metabolism (see below). Never-
theless, although increased BAT uptake of both glucose and
free fatty acids was reported in response to body cooling, it has
been argued that triglyceride metabolism represents the pri-
mary energy source for cold-induced thermogenesis [32].
Despite the focus on BAT, there is evidence that WAT
may also contribute to cold-induced thermogenesis.
Yoneshiro et al. reported that only around 50% of subjects
displayed cold-activated BAT. Despite this, energy expen-
diture following cold exposure in their study also increased
in subjects classiﬁed as BAT negative [18], indicating that
non-BAT tissues may contribute. Because cold exposure
does not appear to increase muscle energy metabolism [51],
cold-induced thermogenesis in WAT could potentially ex-
plain the induced energy expenditure in BAT-negative
subjects. Furthermore, both WAT and BAT are capable of
metabolizing energy by pathways independent of UCP1
[52]; it is therefore possible that both WAT and BAT con-
tribute to thermogenesis in response to tissue cooling. We
note that there may be two components to cold-induced AT
loss, involving (i) rapid energy expenditure by WAT and/or
BAT, followed by (ii) slow AT loss as a result of continued
metabolic activity, possibly including replenishment of
glycogen stores via fat metabolism and, in the longer term,
potentially facilitated by adaptive conversion of WAT to
BAT (“browning”). In support, although falling short of
statistical signiﬁcance, in our study, there was a trend towards
continued AT loss over the days following single procedures.
We also observed that, in a small number of subjects who
were followed up for up to 3 months following multiple serial
procedures, signiﬁcant AT loss continued to take place for an
extended period (Supplementary Materials S4). Nevertheless,
it was not possible to supervise these subjects for potential
changes in activity/exercise and/or caloric intake during the
follow-up period, and continuing changes therefore may not
be unambiguously ascribed to metabolic changes induced by
the cryotherapy procedure.
Regarding the safety of the tissue cryotherapy procedure, no
consistent changes in biochemical parameters were observed
following tissue cooling, includingmarkers of inﬂammation.No
adverse eﬀects were reported by the participants, conﬁrming
previous reports regarding the safety and eﬃcacy of the
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procedure [14, 17, 39–41]. However, there has been discussion
about the possibility that, in mice, prolonged exposure to
subthermoneutral temperatures might predispose to immune
system deﬁciency (e.g., [53]) and could potentially increase the
risk of infection or cancer. However, mice exposed to sub-
thermoneutral temperatures are chronically maintained under
these conditions for months to years. We note that, in humans,
the induction of profound core hypothermia is an accepted
medical procedure in both children and adults for the treatment
of traumatic brain injury [54–56]. Tissue cryotherapy, by
contrast, is an acute local procedure, andwe observed no change
in the body temperature (oral; mean change after the procedure,
+0.3°C; p � NS). We surmise that the beneﬁts of combating
obesity, a major health risk, are likely to substantially exceed the
potential risks, if any, of short-term local tissue exposure to
reduced temperatures. Moreover, the beneﬁts of cryotherapy
may not be restricted to combating obesity: in addition to
reducing measures of obesity through cold-induced fat meta-
bolism, cold exposure can have further beneﬁcial eﬀects such as
promoting HDL turnover and reverse cholesterol transport,
with likely protective eﬀects against atherosclerosis and heart
disease [47].
Our ﬁndings raise a further issue of interest. Does local
tissue cooling cause AT reduction principally in the cooled
tissue (as predicted by the cryolipolysis theory), or is there
a systemic reduction? Following a single procedure, no changes
were observed at a site not exposed to local cooling, but whole-
body scanning indicated signiﬁcant AT losses at nonexposed
sites after three and six sequential procedures (Figure 5, see also
Supplementary Materials S4), indicating that systemic changes
can take place after a longer time period. In addition to sys-
temic depletion of fatty acid levels by BATmetabolism, there
are direct neuronal pathways between AT and the hypothal-
amus, leading to activation of the sympathetic nervous system
and the release of noradrenaline (NA) that promotes BAT
activity (reviewed in [57]). A further contender is that systemic
AT lossmay bemediated by cytokines released from the cooled
tissue, such as ﬁbroblast growth factor type 21 and interleukin-
6 (reviewed in [23, 58]), that might act both centrally (e.g., via
the hypothalamus) and peripherally to modulate systemic fat
metabolism (reviewed in [29]). In support, BAT trans-
plantation inmice can induce systemic changes in the recipient
([58] for review). Behavioral changes (e.g., activity and food
consumption) potentially mediated by endocrine targeting of
the hypothalamus and/or hippocampus [59] may also take
place, and further studies on the complex neuroendocrine
interplay between body temperature, BAT and WAT fat
metabolism, and adaptive behavior are warranted.
In summary, this work addresses the competing cry-
olipolysis versus cryothermogenesis interpretations of the
mechanism underlying tissue cooling as a remedial therapy for
overweight/obesity. In agreement with the previous work, local
cooling of abdominal fatty tissue signiﬁcantly reduced the
measures of obesity, including waist circumference, body
weight, BMI, and fat content. Our central observations are that
(i) repeat procedures at short timescales produce progressive
losses of AT, a ﬁnding inconsistent with “cryolipolysis” that is
inferred to require weeks or longer between sequential treat-
ments; (ii) blood proﬁling after the tissue cooling procedure
gave no evidence ofmarkers of inﬂammation or cell disruption;
and (iii) calculated weight loss through thermogenesis alone
was substantially consistent with estimates of heat extracted
versus compensatory heat generation through enhanced tissue
metabolism and thermogenesis. Our ﬁndings indicate that
cold-induced thermogenesis (cryothermogenesis) rather than
adipose tissue disruption is likely to underlie the observed
reductions inmeasures of obesity following local tissue cooling.
Conflicts of Interest
Suvaddhana Loap is a medical director of a clinic providing
tissue cryotherapy for obesity/overweight. Richard Lathe
declares no competing interests.
Acknowledgments
*e authors thank all the subjects who participated in this
work and kindly gave permission for their data to be in-
cluded in this publication. Ms. B. Levacher is thanked for
blood sampling and Dr. A. Springbett for advice on sta-
tistical analysis. *e authors thank Dr. Claude Dalle for
critical comments on the manuscript.
Supplementary Materials
S1: biomedical parameters. S2: consistency of weight loss
versus physical dimensions. S3: consistency of energy
extracted and weight loss. S4: evidence for long-term changes
following cryotherapy. (Supplementary Materials)
References
[1] C. J. Lavie and R. V. Milani, “Obesity and cardiovascular
disease: the hippocrates paradox?,” Journal of the American
College of Cardiology, vol. 42, no. 4, pp. 677–679, 2003.
[2] P. Kopelman, “Health risks associated with overweight and
obesity,” Obesity Reviews, vol. 8, no. 1, pp. 13–17, 2007.
[3] J. Kaur, “A comprehensive review on metabolic syndrome,”
Cardiology Research and Practice, vol. 2014, Article ID 943162,
21 pages, 2014.
[4] H. Buchwald, Y. Avidor, E. Braunwald et al., “Bariatric
surgery: a systematic review and meta-analysis,” JAMA,
vol. 292, no. 14, pp. 1724–1737, 2004.
[5] J. D. Peterson and M. P. Goldman, “Laser, light, and energy
devices for cellulite and lipodystrophy,” Clinics in Plastic
Surgery, vol. 38, no. 3, pp. 463–474, 2011.
[6] J. A. Lennon, W. J. Brech, and E. S. Gordon, “Eﬀect of a short
period of cold exposure on plasma FFA level in lean and obese
humans,” Metabolism: Clinical and Experimental, vol. 16,
no. 6, pp. 503–506, 1967.
[7] W. J. O’Hara, C. Allen, and R. J. Shephard, “Treatment of
obesity by exercise in the cold,” CanadianMedical Association
Journal, vol. 117, pp. 773–778, 1977.
[8] T. Yoneshiro, S. Aita, M. Matsushita et al., “Age-related
decrease in cold-activated brown adipose tissue and accu-
mulation of body fat in healthy humans,” Obesity, vol. 19,
no. 9, pp. 1755–1760, 2011.
[9] D. P. Blondin, S. M. Labbe´, H. C. Tingelstad et al., “Increased
brown adipose tissue oxidative capacity in cold-acclimated
humans,” Journal of Clinical Endocrinology & Metabolism,
vol. 99, no. 3, pp. E438–E446, 2014.
8 Journal of Obesity
[10] S. N. Cheuvront, M. A. Kolka, B. S. Cadarette, S. J. Montain,
and M. N. Sawka, “Eﬃcacy of intermittent, regional micro-
climate cooling,” Journal of Applied Physiology, vol. 94, no. 5,
pp. 1841–1848, 2003.
[11] J. S. Nelson, B. Majaron, and K. M. Kelly, “Active skin cooling
in conjunction with laser dermatologic surgery,” Seminars in
Cutaneous Medicine and Surgery, vol. 19, no. 4, pp. 253–266,
2000.
[12] D. Manstein, H. Laubach, K. Watanabe, W. Farinelli,
D. Zurakowski, and R. R. Anderson, “Selective cryolysis:
a novel method of non-invasive fat removal,” Lasers in Surgery
and Medicine, vol. 40, no. 9, pp. 595–604, 2008.
[13] S. R. Coleman, K. Sachdeva, B. M. Egbert, J. Preciado, and
J. Allison, “Clinical eﬃcacy of noninvasive cryolipolysis and
its eﬀects on peripheral nerves,” Aesthetic Plastic Surgery,
vol. 33, no. 4, pp. 482–488, 2009.
[14] M. M. Avram and R. S. Harry, “Cryolipolysis for sub-
cutaneous fat layer reduction,” Lasers in Surgery and Medi-
cine, vol. 41, no. 10, pp. 703–708, 2009.
[15] H. R. Jalian and M. M. Avram, “Cryolipolysis: a historical
perspective and current clinical practice,” Seminars in Cu-
taneous Medicine and Surgery, vol. 32, no. 1, pp. 31–34, 2013.
[16] B. Zelickson, B. M. Egbert, J. Preciado et al., “Cryolipolysis for
noninvasive fat cell destruction: initial results from a pigmodel,”
Dermatologic Surgery, vol. 35, no. 10, pp. 1462–1470, 2009.
[17] A. A. Nelson, “Cooling for fat,” in Fat Removal, pp. 101–118,
John Wiley & Sons, Hoboken, NJ, USA, 2015.
[18] T. Yoneshiro, S. Aita, M. Matsushita et al., “Recruited brown
adipose tissue as an antiobesity agent in humans,” Journal of
Clinical Investigation, vol. 123, no. 8, pp. 3404–3408, 2013.
[19] A. A. van der Lans, J. Hoeks, B. Brans et al., “Cold acclimation
recruits human brown fat and increases nonshivering ther-
mogenesis,” Journal of Clinical Investigation, vol. 123, no. 8,
pp. 3395–3403, 2013.
[20] L. Ye, J.Wu, P. Cohen et al., “Fat cells directly sense temperature
to activate thermogenesis,” Proceedings of the National Academy
of Sciences, vol. 110, no. 30, pp. 12480–12485, 2013.
[21] Y. Deng and P. E. Scherer, “Adipokines as novel biomarkers
and regulators of the metabolic syndrome,” Annals of the New
York Academy of Sciences, vol. 1212, no. 1, pp. E1–E19, 2010.
[22] P. Trayhurn, C. Bing, and I. S. Wood, “Adipose tissue and
adipokines-energy regulation from the human perspective,”
Journal of Nutrition, vol. 136, no. 7, pp. 1935S–1939S, 2006.
[23] F. Villarroya, R. Cereijo, J. Villarroya, and M. Giralt, “Brown
adipose tissue as a secretory organ,” Nature Reviews Endo-
crinology, vol. 13, no. 1, pp. 26–35, 2017.
[24] D. M. Huﬀman and N. Barzilai, “Contribution of adipose
tissue to health span and longevity,” Interdisciplinary Topics in
Gerontology, vol. 37, pp. 1–19, 2010.
[25] C. Meisinger, A. Doring, B. *orand, M. Heier, and H. Lowel,
“Body fat distribution and risk of type 2 diabetes in the general
population: are there diﬀerences between men and women?
*e MONICA/KORA Augsburg Cohort Study,” American
Journal of Clinical Nutrition, vol. 84, no. 3, pp. 483–489, 2006.
[26] T. Pischon, H. Boeing, K. Hoﬀmann et al., “General and
abdominal adiposity and risk of death in Europe,” New En-
gland Journal of Medicine, vol. 359, no. 20, pp. 2105–2120,
2008.
[27] J. Nedergaard, T. Bengtsson, and B. Cannon, “Unexpected
evidence for active brown adipose tissue in adult humans,”
American Journal of Physiology-Endocrinology and Meta-
bolism, vol. 293, no. 2, pp. E444–E452, 2007.
[28] S. Enerback, “Brown adipose tissue in humans,” International
Journal of Obesity, vol. 34, no. 1, pp. S43–S46, 2010.
[29] P. Lee, M. M. Swarbrick, and K. K. Ho, “Brown adipose tissue
in adult humans: a metabolic renaissance,” Endocrine Reviews,
vol. 34, no. 3, pp. 413–438, 2013.
[30] A. Bartelt, O. T. Bruns, R. Reimer et al., “Brown adipose tissue
activity controls triglyceride clearance,” Nature Medicine,
vol. 17, no. 2, pp. 200–205, 2011.
[31] H. Sacks andM. E. Symonds, “Anatomical locations of human
brown adipose tissue: functional relevance and implications
in obesity and type 2 diabetes,” Diabetes, vol. 62, no. 6,
pp. 1783–1790, 2013.
[32] V. Ouellet, S. M. Labbe, D. P. Blondin et al., “Brown adipose
tissue oxidative metabolism contributes to energy expenditure
during acute cold exposure in humans,” Journal of Clinical
Investigation, vol. 122, no. 2, pp. 545–552, 2012.
[33] M. Florez-Duquet and R. B. McDonald, “Cold-induced
thermoregulation and biological aging,” Physiological Re-
views, vol. 78, no. 2, pp. 339–358, 1998.
[34] L. J. Bukowiecki, A. Geloen, and A. J. Collet, “Proliferation
and diﬀerentiation of brown adipocytes from interstitial cells
during cold acclimation,” American Journal of Physiology,
vol. 250, no. 6, pp. C880–C887, 1986.
[35] M. Rosenwald, A. Perdikari, T. Rulicke, and C. Wolfrum, “Bi-
directional interconversion of brite and white adipocytes,”
Nature Cell Biology, vol. 15, no. 6, pp. 659–667, 2013.
[36] Y. H. Lee, A. P. Petkova, A. A. Konkar, and J. G. Granneman,
“Cellular origins of cold-induced brown adipocytes in adult
mice,” @e FASEB Journal, vol. 29, no. 1, pp. 286–299, 2015.
[37] M. Petruzzelli, M. Schweiger, R. Schreiber et al., “A switch
from white to brown fat increases energy expenditure in
cancer-associated cachexia,” Cell Metabolism, vol. 20, no. 3,
pp. 433–447, 2014.
[38] L. S. Sidossis, C. Porter, M. K. Saraf et al., “Browning of sub-
cutaneous white adipose tissue in humans after severe adren-
ergic stress,” Cell Metabolism, vol. 22, no. 2, pp. 219–227, 2015.
[39] N. Krueger, S. V. Mai, S. Luebberding, and N. S. Sadick,
“Cryolipolysis for noninvasive body contouring: clinical ef-
ﬁcacy and patient satisfaction,” Clinical, Cosmetic and In-
vestigational Dermatology, vol. 7, pp. 201–205, 2014.
[40] C. D. Derrick, S. M. Shridharani, and J. M. Broyles, “*e safety
and eﬃcacy of cryolipolysis: a systematic review of available
literature,” Aesthetic Surgery Journal, vol. 35, no. 7, pp. 830–
836, 2015.
[41] J. Kennedy, S. Verne, R. Griﬃth, L. Falto-Aizpurua, and
K. Nouri, “Non-invasive subcutaneous fat reduction: a re-
view,” Journal of the European Academy of Dermatology and
Venereology, vol. 29, no. 9, pp. 1679–1688, 2015.
[42] J. Fujita, “Cold shock response in mammalian cells,” Journal
of Molecular Microbiology and Biotechnology, vol. 1, no. 2,
pp. 243–255, 1999.
[43] L. A. Sonna, J. Fujita, S. L. Gaﬃn, and C. M. Lilly, “Invited
review: eﬀects of heat and cold stress on mammalian gene
expression,” Journal of Applied Physiology, vol. 92, no. 4,
pp. 1725–1742, 2002.
[44] J. Dempersmier, A. Sambeat, O. Gulyaeva et al., “Cold-
inducible Zfp516 activates UCP1 transcription to promote
browning of white fat and development of brown fat,” Mo-
lecular Cell, vol. 57, no. 2, pp. 235–246, 2015.
[45] M. Saito, Y. Okamatsu-Ogura, M. Matsushita et al., “High
incidence of metabolically active brown adipose tissue in
healthy adult humans: eﬀects of cold exposure and adiposity,”
Diabetes, vol. 58, no. 7, pp. 1526–1531, 2009.
[46] G. Haemmerle, “Defective lipolysis and altered energy
metabolism in mice lacking adipose triglyceride lipase,”
Science, vol. 312, no. 5774, pp. 734–737, 2006.
Journal of Obesity 9
[47] A. Bartelt, C. John, N. Schaltenberg et al., “*ermogenic
adipocytes promote HDL turnover and reverse cholesterol
transport,” Nature Communications, vol. 8, p. 15010, 2017.
[48] A. L. Vallerand and I. Jacobs, “Rates of energy substrates
utilization during human cold exposure,” European Journal of
Applied Physiology and Occupational Physiology, vol. 58, no. 8,
pp. 873–878, 1989.
[49] R. Greco-Perotto, D. Zaninetti, F. Assimacopoulos-Jeannet,
E. Bobbioni, and B. Jeanrenaud, “Stimulatory eﬀect of cold
adaptation on glucose utilization by brown adipose
tissue. Relationship with changes in the glucose transporter
system,” Journal of Biological Chemistry, vol. 262, no. 16,
pp. 7732–7736, 1987.
[50] C. Olichon-Berthe, O. E. Van, and Y. Le Marchand-Brustel,
“Eﬀect of cold acclimation on the expression of glucose
transporter Glut 4,” Molecular and Cellular Endocrinology,
vol. 89, no. 1-2, pp. 11–18, 1992.
[51] J. Orava, P. Nuutila, M. E. Lidell et al., “Diﬀerent metabolic
responses of human brown adipose tissue to activation by cold
and insulin,” Cell Metabolism, vol. 14, no. 2, pp. 272–279,
2011.
[52] P. Flachs, M. Rossmeisl, O. Kuda, and J. Kopecky, “Stimu-
lation of mitochondrial oxidative capacity in white fat in-
dependent of UCP1: a key to lean phenotype,” Biochimica et
Biophysica Acta, vol. 1831, no. 5, pp. 986–1003, 2013.
[53] B. L. Hylander and E. A. Repasky, “*ermoneutrality, mice,
and cancer: a heated opinion,” Trends in Cancer, vol. 2, no. 4,
pp. 166–175, 2016.
[54] K. Peterson, S. Carson, and N. Carney, “Hypothermia treatment
for traumatic brain injury: a systematic review andmeta-analysis,”
Journal of Neurotrauma, vol. 25, no. 1, pp. 62–71, 2008.
[55] K. R. Diller and L. Zhu, “Hypothermia therapy for brain
injury,” Annual Review of Biomedical Engineering, vol. 11,
no. 1, pp. 135–162, 2009.
[56] R. Mosalli, “Whole body cooling for infants with hypoxic-
ischemic encephalopathy,” Journal of Clinical Neonatology,
vol. 1, no. 2, pp. 101–106, 2012.
[57] B. Cannon and J. Nedergaard, “Brown adipose tissue: function
and physiological signiﬁcance,” Physiological Reviews, vol. 84,
no. 1, pp. 277–359, 2004.
[58] A. Bartelt and J. Heeren, “Adipose tissue browning and
metabolic health,” Nature Reviews Endocrinology, vol. 10,
no. 1, pp. 24–36, 2014.
[59] R. Lathe, “Hormones and the hippocampus,” Journal of
Endocrinology, vol. 169, no. 2, pp. 205–231, 2001.
10 Journal of Obesity
Stem Cells 
International
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
MEDIATORS
INFLAMMATION
of
Endocrinology
International Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Disease Markers
Hindawi
www.hindawi.com Volume 2018
BioMed 
Research International
Oncology
Journal of
Hindawi
www.hindawi.com Volume 2013
Hindawi
www.hindawi.com Volume 2018
Oxidative Medicine and 
Cellular Longevity
Hindawi
www.hindawi.com Volume 2018
PPAR Research
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013www.hindawi.com
The Scientific 
World Journal
8
Immunology Research
Hindawi
www.hindawi.com Volume 2018
Journal of
Obesity
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
 Computational and  
Mathematical Methods 
in Medicine
Hindawi
www.hindawi.com Volume 2018
Behavioural 
Neurology
Ophthalmology
Journal of
Hindawi
www.hindawi.com Volume 2018
Diabetes Research
Journal of
Hindawi
www.hindawi.com Volume 2018
Hindawi
www.hindawi.com Volume 2018
Research and Treatment
AIDS
Hindawi
www.hindawi.com Volume 2018
Gastroenterology 
Research and Practice
Hindawi
www.hindawi.com Volume 2018
Parkinson’s 
Disease
Evidence-Based 
Complementary and
Alternative Medicine
Volume 2018
Hindawi
www.hindawi.com
Submit your manuscripts at
www.hindawi.com
